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Abstract
Renal angiomyolipoma is a rare cause of renal tumor in children. Most are associated with tuberous sclerosis, and the classic type is observed 
more commonly. Epithelioid angiomyolipoma is even rarer with only limited case reports and series published in literature, most of which are 
of adult patients. We describe a 12-year-old boy, a diagnosed patient of tuberous sclerosis, who presented with pain in the left flank. On evalua-
tion, it was found to have a left renal mass with the clinical picture suggestive of renal cell carcinoma. Partial nephrectomy was performed and 
histopathology revealed epithelioid angiomyolipoma. The child was asymptomatic at follow-up after 3 months. Only a few such cases in children 
are found in literature, which are discussed alongside. Differential diagnosis of this rare tumor must be kept in mind in a renal tumor as surgery 
is generally curative in this possibly malignant tumor. Metastasis confers a poor prognosis. Chemotherapy is generally not effective, although 
various regimens have been tried. Tumor recurrence must be kept in mind and a follow-up after apparent complete remission is of paramount 
importance.
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Renal epithelioid angiomyolipoma (EAML), described 
much more frequently in adults, is an extremely rare tumor 
in pediatrics. Most cases are associated with tuberous sclero-
sis. There is a definite malignant potential inherently associ-
ated with EAML, evident from published reports of distant 
metastasis in rare cases (1, 2). This is in contrast to the rea-
sonably benign course of classic angiomyolipoma (AML). 
Resection is invariably required, with prognosis greatly 
dependent on the presence of metastasis. A case of EAML 
in a child with tuberous sclerosis is described in which partial 
nephrectomy was curative with a good outcome. As per 
available adult literature, one-third of cases show advanced 
disease necessitating expeditious treatment and close fol-
low-up, not dissimilar to renal cell carcinoma (RCC) (3). 
Case Report
A 12-year-old male child presented with episodic 
mild-to-moderate pain in the left flank for 1 month. There 
was no associated abdominal distension, lump, hematuria, 
fever, vomiting, or any other urinary complaints. There was 
no past history of any surgery. The child was diagnosed with 
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tuberous sclerosis at the age of 8 years, when he presented 
with multiple seizures and skin manifestations characteristic 
of tuberous sclerosis. Previous abdominal ultrasonography 
performed at the age of 11 years was unremarkable. The 
child was well built with a visible shagreen patch, ash leaf 
macules, periungual fibromas, and hypomelanotic patches 
(Figure 1). On abdominal examination, a vague lump was 
palpable in the left lumbar and left hypochondrium with 
fullness of left renal angle. There was no history of tuberous 
sclerosis, malignancy, or renal disorder in any of the family 
members. Germline testing was not conducted.
An abdominal ultrasound revealed multiple well-defined 
elongated echogenic focal lesions close to the cortex in the 
right and left kidney, suggesting multiple angiomyolipo-
mas, largest being 1.4 × 1.2 cm in size and a separate mass 
 arising from the lower pole of the left kidney (Figure 2). 
A contrast-enhanced computed tomography (CECT) of the 
chest and abdomen was performed, which revealed bilateral, 
multiple, small, non-calcified, and enhancing cortical lesions 
containing fat that was suggestive of renal angiomyolipomas. 
Alongside, a 11 × 10 × 9 cm heterogeneously enhancing exo-
phytic solid mass was seen arising from the lower pole of the 
left kidney causing mild left ureteric compression and mild 
hydroureteronephrosis (Figure 3). The mass had no fat com-
ponent. A provisional diagnosis of left RCC was kept, with 
the rare possibility of epithelioid angiomyolipoma due to the 
rarity of this tumor.
On laparotomy, there was a tumor arising from the lower 
pole of the left kidney reaching up to the pelvis. The ureter, 
renal vessels, inferior vena cava, and surrounding organs 
were free of tumor. Left partial nephrectomy was performed, 
taking rim of normal surrounding renal tissue. The patient 





Figure 1: External clinical manifestations of tuberous sclerosis 
in the patient. (A) Facial angiofibromas in a classic butterfly 
pattern, adenoma sebaceum. Also seen is a typical forehead 
fibrous plaque, often seen as an early sign of tuberous  sclerosis. 
(B) Multiple hypomelanic macules on the right lower limb, 
also known as ash leaf spots, caused due to lack of melanin. 
(C)  Similar hypomelanic macule on the anterior chest wall. 
(D) Ungual fibroma/Koenen’s tumor present on the left 3rd toe.
A B
Figure 2: (A, B) Ultrasound images of the left kidney reveal multiple elongated echogenic focal lesions close to the cortex, sug-
gesting angiomyolipomas. Note the mass from the lower pole (m).
Overall, it was a tan brown, friable, well-circumscribed, and 
encapsulated tumor measuring 9 × 8.5 × 5 cm. On microscopic 
examination, the tumor was examined as predominantly 
composed of epithelioid (polygonal) cells, with focal areas 
showing thick-walled blood vessels and interspersed fat cells. 
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similar lesions arising at a variety of visceral and soft tis-
sue sites (6). This classification is based on the presence of 
a characteristic cell type—the perivascular epithelioid cell 
(PEC) in all these neoplasms. This further convolutes the 
pathological diagnosis of this entity concerning whether it is 
hamartoma, choristoma, or true neoplasm (7). No definitive 
etiological basis has been described in its pathogenesis.
A literature search to the best of our knowledge brought to 
light roughly 200 odd cases of EAML in adults and six cases 
in the pediatric population aged less than 18 years. The most 
common clinical presentation in the pediatric population is 
an abdominal lump, followed by abdominal pain. Associated 
history of tuberous sclerosis in a patient with renal lump 
vehemently insinuates the possibility of AML. Abdomi-
nal ultrasonography and CECT reveal renal mass with few 
definitive differentiating factors. The dearth of macroscopic 
fat in CT is a classic feature that differentiates classic AML 
from EAML, although infrequently macroscopic fat may 
not be visible even in classic AML. Calcifications, if  seen, 
point more toward a diagnosis of RCC. Recently, chemical 
shift magnetic resonance imaging (MRI) has been reported 
for distinguishing minimal-fat renal AML from RCC (8), 
although it has not been studied in EAML. Dual-tracer pos-
itron emission tomography (PET)/CT has been also found 
use in differentiating fat-poor AML from RCC (7). However, 
in most instances, as in our patient; definitive distinguish-
ing features between EAML and RCC are seldom present 
in CT. Thus, early prognostication remains an arduous job, 
or rather implausible, since EAML might have malignant 
potential and RCC has a poorer outcome than the relatively 
benign classic AML.
The presence of malignant potential in EAML has been 
attributed to the presence of tuberous sclerosis syndrome, 
extra-renal extension or renal vein involvement, tumor 
There were large areas of necrosis and perinecrotic tumor cells 
pointing moderate nuclear atypia and prominent nucleoli. 
There were satellite nodules in adjoining renal parenchyma. 
On immunohistochemistry, the tumor cells were immunoposi-
tive for HMB45, Melan A, and S100  (Figure 4). Based on the 
above-mentioned histomorphological and immunohistochem-
ical features, it was diagnosed as epithelioid angiomyolipoma. 
The tumor was 0.1 cm away from the renal capsule, <0.1 cm 
from the resected margin, 0.2 cm from perirenal fat. Genomic 
testing of the tumor tissue was not performed.
Evaluation of the patient on follow-up at 3 months was 
unremarkable.
Discussion
Renal angiomyolipoma is an uncommon cause of renal mass 
in children, which is classified as of either benign triphasic 
type (including classic AML and fat-poor AML) or poten-
tially malignant epithelioid AML. As the name suggests, 
AML comprises a mixture of mature adipose tissue, smooth 
muscle cells, and blood vessels. AML is considered to be a 
benign clonal mesenchymal neoplasm (4), which is mainly 
renal in origin, albeit rarely arising from the liver. Both spo-
radic and syndromic types have been described, most com-
monly associated with the tuberous sclerosis complex (TSC), 
which is a group of autosomal dominant genetic disorders 
caused by germline mutations in TSC1 or TSC2 genes (5). 
Proteins hamartin and tuberin are encoded by TSC1 and 
TSC2 genes, respectively.
Recently, it has been further classified under a family of 
related mesenchymal neoplasms named “PEComas,” which 
includes angiomyolipoma, an entity called clear cell sugar 
tumor (CCSK) of the lung, lymphangiomyomatosis, and a 
group of rare, morphologically, and immunophenotypically 
A B
Figure 3: Images of (A) axial and (B) coronal CECT of the abdomen reveal exophytic heterogeneously enhancing solid mass 
(arrow) arising from the left kidney. The mass has no fat component in it. 
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Figure 4: Histopathological findings of epithelioid angiomyolipoma. (A) Section from the mass shows a tumor predominantly 
composed of polygonal cells with focally present thick vessels and interspersed fat cells (hematoxylin and eosin × 40). (B) The 
tumor cells are predominantly epithelioid (polygonal), arranged in a nesting pattern (hematoxylin and eosin × 100). Inset com-
prised a high magnification image of tumor where tumor cells show moderate to abundant and clear to granular eosinophilic 
cytoplasm with distinct cytoplasmic boundries (hematoxylin and eosin × 200). (C) The tumor also shows large areas of necrosis. 
The surrounding tumor cells show moderate nuclear atypia and prominent nucleoli (hematoxylin and eosin × 200). (D) Tumor 
cells are immunopositive for HMB45 (× 200).
necrosis, carcinoma-type histology, and a tumor size of more 
than 7 cm (9). Only two cases of malignant EAML have been 
described in the pediatric population, one of which had the 
presence of tuberous sclerosis syndrome and another had 
extra-renal extension (1, 2). Presence of nuclear atypia or 
atypical mitosis could be the pointers for a possibility of an 
aggressively behaving tumor.
Surgery is the treatment of choice and is curative in most 
cases. Imaging is seldom able to convincingly rule out RCC, 
especially in an older children. Hence, resection is both diag-
nostic and therapeutic. Presence of metastasis dampens the 
survival rate. Various chemotherapeutic regimens have been 
tried in malignant EAML, without much success and the 
prognosis remains dismal in such cases. Tuberous sclerosis 
is caused by a decreased or absent expression of hamartin 
or tuberin. The hamartin–tuberin complex normally inhib-
its mammalian target of rapamycin complex 1 (mTORC1) in 
a cell. The loss of this complex in tuberous sclerosis leads 
to activation of constitutive mTORC1, leading to aberrant 
cellular signaling, and thus heading to tumor growth such 
as angiomyolipoma. Everolimus is a rapamycin derivative 
that inhibits the mTOR pathway by acting on mTORC1. In 
a randomized trial, everolimus was found to reduce volume 
of angiomyolipoma with an acceptable safety profile (10). 
Sirolimus, another mTOR inhibitor, has been found to have 
a role in angiomyolipoma, subependymal giant-cell astrocy-
toma, and lymphangioleiomyomatosis associated with tuber-
ous sclerosis (11). These drugs could play a major role in the 
prospective future management protocols for tuberous scle-
rosis-associated angiomyolipoma.
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Nephron sparing surgery has a definite role, as the goal 
must always be renal preservation as these patients might 
also have associated other angiomyolipomas. As in our 
patient, partial nephrectomy was generally possible, and 
must be strived for. Nese et al. established recurrence after 
complete resection in five of 33 adult patients at a mean 
period of 32 months (9). Similarly, recurrence is seen in two 
of six pediatric patients as described in Table 1. This neces-
sitates a vigorous follow-up even after curative surgery and 
complete remission. 
Since very few pediatric cases are reported, it is difficult 
to predict relapse rate in this group. According to adult lit-
erature, proportions of relapse and metastasis are 17% and 
49%, respectively (9). The median time of metastasis during 
follow-up is 12–18 months (1). Thus, a diligent follow-up 
with close monitoring is of paramount importance, consid-
ering the known potential for recurrence and metastasis. 
A 3-month follow-up with clinical evaluation and rele-
vant radiological investigations for 2 years is imperative for 
EAML. An abdominal ultrasound alternated with a CT scan 
seems a reasonable option to ensure a good yield of pick-
ing up any relapse. Biannual follow-up up to 5 years must be 
undertaken followed by annual follow-up as is the protocol 
for most tuberous sclerosis patients.
Conclusion
EAML is seen sporadically in children, but in patients diag-
nosed with tuberous sclerosis, this must be kept in the dif-
ferential. Conventional imaging is rarely conclusive. Use of 
chemical shift MRI and dual-tracer PET/CT is considered, 
but evidence-based validation is lacking. Surgery is the 
treatment of choice, with the goal being nephron-sparing 
surgery. Stringent follow-up is imperative as recurrence is a 
possibility. 
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